We found that SRT2104—a potent activator of SIRT1—attenuated diabetes‐induced aortic oxidative stress, inflammation and endothelial dysfunction in STZ‐induced diabetic mice through inhibition of P53.74 Here, TP53 is linked to endothelial dysfunction.